Acute Myeloid Leukemia (AML) Hospitalizations: Racial Disparity in Outcomes of Patients with Comorbidities

被引：1
|
作者：
Alam, Sara Taveras [1 ,2 ]
Dongarwar, Deepa [3 ]
Lopez, Elyse [4 ]
Yellapragada, Sarvari Venkata [1 ,2 ]
Rivero, Gustavo [1 ]
Miller-Chism, Courtney Nicole [1 ]
Mims, Martha P. [1 ]
Huang, Quillan [1 ,2 ]
Salihu, Hamisu [3 ]
机构：
[1] Baylor Coll Med, Dept Med, Sect Hematol & Oncol, Houston, TX 77030 USA
[2] Michael E DeBakey VA Med Ctr, Houston, TX USA
[3] Baylor Coll Med, Ctr Excellence Hlth Equ Training & Res, Houston, TX USA
[4] Baylor Coll Med, Dept Med, Houston, TX USA
来源：
BLOOD | 2021年 / 138卷
关键词：
D O I：
10.1182/blood-2021-153029
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
4135
引用
收藏
页数：4
相关论文
共 50 条
  • [41] Polyclonal normal hematopoietic progenitors in patients with acute myeloid leukemia (AML).
    Guan, YH
    Ralph, S
    Ling, V
    Hogge, DE
    BLOOD, 2001, 98 (11) : 765A - 765A
  • [42] Quality of Life and Psychological Distress in Patients with Acute Myeloid Leukemia (AML)
    El-Jawahri, Areej
    Waldman, Lauren
    Greer, Joseph
    Abel, Gregory A.
    Steensma, David P.
    Brunner, Andrew M.
    Fathi, Amir T.
    DeAngelo, Daniel J.
    Wadleigh, Martha
    Hobbs, Gabriela S.
    Amrein, Philip C.
    Stone, Richard M.
    Temel, Jennifer S.
    BLOOD, 2018, 132
  • [43] Treatment outcome of acute myeloid leukemia (AML) in HIV plus patients
    Dy, Irene Ang
    Patchett, Matthew
    McDonald, Alicia
    Wiernik, Peter H.
    JOURNAL OF CLINICAL ONCOLOGY, 2012, 30 (15)
  • [44] FLOWCYTOMETRIC IMMUNOPHENOTYPIC CHARACTRIZATION OF ACUTE MYELOID LEUKEMIA (AML) PATIENTS IN SUDAN
    Humeida, Amira
    Osman, Ihsan
    Elhadi, Taghreed
    Altayeb, Osama
    INTERNATIONAL JOURNAL OF LABORATORY HEMATOLOGY, 2014, 36 : 99 - 99
  • [45] Treatment Patterns and Outcomes of Patients with NPM1+Acute Myeloid Leukemia (AML) Enrolled in the CONNECT® Myeloid Disease Registry
    Pollyea, Daniel A.
    Maciejewski, Jaroslaw P.
    Roboz, Gail J.
    Seiter, Karen
    Scott, Bart L.
    DeGutis, Irene S.
    Kiselev, Pavel
    Yu, Edward
    McBride, Ali
    Heydendael, Willem
    Erba, Harry P.
    BLOOD, 2022, 140 : 11844 - 11846
  • [46] Mylotarg in the therapy of acute myeloid leukemia (AML).
    Weber-Nordt, RM
    Lenze, A
    Gottschling, S
    Steiger, S
    Ho, AD
    BLOOD, 2001, 98 (11) : 225B - 225B
  • [47] ACUTE MYELOID LEUKEMIA (AML)-PROGRESS AND PROMISES
    Kantarjian, Hagop
    LEUKEMIA RESEARCH, 2016, 49 : S2 - S3
  • [48] New agents in acute myeloid leukemia (AML)
    Park, Silvia
    Cho, Byung Sik
    Kim, Hee-Je
    BLOOD RESEARCH, 2020, 55 : 14 - 18
  • [49] Chromosomal rearrangements in acute myeloid leukemia (AML)
    Belloni, E.
    Trubia, M.
    Gasparini, P.
    Micucci, C.
    Tapinassi, C.
    Confalonieri, S.
    Nuciforo, P.
    Martino, B.
    Lo-Coco, F.
    Di Fiore, P. P.
    Pelicci, P. G.
    ECANCERMEDICALSCIENCE, 2010, 4
  • [50] THERAPEUTIC TARGETS FOR ACUTE MYELOID LEUKEMIA (AML)
    Sorbera, L. A.
    Verges, C.
    Dulsat, C.
    DRUGS OF THE FUTURE, 2009, 34 (01) : 67 - 77
12345